ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $703,310 | -54.6% | 17,340 | -63.0% | 0.00% | -60.0% |
| Q3 2022 | $1,548,000 | -49.3% | 46,843 | -46.0% | 0.01% | -47.4% |
| Q2 2022 | $3,056,000 | -0.0% | 86,793 | +30.6% | 0.02% | +26.7% |
| Q1 2022 | $3,057,000 | +44.6% | 66,474 | +108.5% | 0.02% | +50.0% |
| Q4 2021 | $2,114,000 | -49.0% | 31,878 | -51.9% | 0.01% | -54.5% |
| Q3 2021 | $4,142,000 | +43.0% | 66,343 | +89.7% | 0.02% | +46.7% |
| Q2 2021 | $2,896,000 | +1721.4% | 34,970 | -64.3% | 0.02% | +1400.0% |
| Q2 2017 | $159,000 | +231.2% | 97,875 | +275.0% | 0.00% | – |
| Q1 2017 | $48,000 | – | 26,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |